CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
24,007 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
May 2026 data show mortgage lock volume slid 9% from April as higher rates cooled demand. Purchases led the market, w...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
May CPI data show inflation just roared back above 4% driven by energy costs, while some grocery prices ease. Investo...
Caterpillar stock is edging toward its 52-week high as orders surge and the Power & Energy arm expands. Yet investors...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...
Microsoft stock slipped today as tech sector headwinds and a workforce headline weighed on the shares. This article b...
Protests flare along the Albanian Adriatic coast over a Kushner-linked resort plan, pitting job hopes against environ...
A couple in their mid-60s weighs the cost of restoring classic cars against steady portfolio income as market conditi...
With his 80th birthday approaching, Trump orchestrates high-profile appearances and a major White House event to proj...
The canadian prime minister mark warns that U.S. export controls on Anthropic’s latest AI models show the dangers of ...